Biovac, a leading South African vaccine manufacturer, modernized its pharmacovigilance by replacing outdated paper-based systems with IQVIA’s Vigilance Platform. Facing challenges of a small PV team, labor-intensive processes, and new SAHPRA rules mandating electronic submissions, Biovac needed efficiency and compliance. IQVIA’s solution cut manual data entry—which consumed 90% of staff time—by automating workflows, reporting, and metrics tracking. The platform improved compliance, accuracy, and quality control while being user-friendly and scalable. This partnership strengthened Biovac’s operations, supporting future global expansion and innovation in vaccine safety.

Join for free to read